Skip to content
Clinical Trials – home

Diamond Clinic Sp. z o.o.

Verified siteinfoFast reply

Poland ul. Stefana Rogozinskiego 6/ U3, 31-559 Cracow, Poland

  • 1 trial recruiting
  • Psoriasis · Chronic obstructive pulmonary disease · Asthma
  • Adult patients

About Specializations

Diamond Clinic Sp. z o.o. in Cracow, Poland specialises in clinical trials of conditions such as Psoriasis, Chronic obstructive pulmonary disease, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The research at Diamond Clinic focuses on Chronic Obstructive Pulmonary Disease (COPD) and moderate-to-severe asthma, evaluating new biologic agents aimed at reducing the frequency and severity of acute exacerbations.

  • Astegolimab efficacy in COPD
  • Rocatinlimab efficacy in asthma
  • Reduction of moderate and severe exacerbations
  • Placebo‑controlled safety assessments

Located in Cracow, Poland, the site collaborates with local investigators to advance therapeutic options for patients with chronic lung conditions.

Immune System Phenomena

Studies explore the role of the immune system in respiratory disease, testing antibodies that modulate immune pathways to improve disease control.

  • Targeted immunotherapy for airway inflammation
  • Biomarker analysis of immune response
  • Safety profiling of immune‑modulating agents

The clinic’s work contributes to a deeper understanding of immune‑driven mechanisms in lung disease, supporting future treatment development.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Stefana Rogozinskiego 6/ U331-559 CracowPoland
Recruiting now
1 trial
Conditions studied
3
Partner status
Verified site

More sites in CracowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Psoriasis

Not recruiting

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Envudeucitinib
  • Sponsor:Alumis Inc.

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Asthma

Not recruiting

Study of rocatinlimab compared to placebo to help adults with Moderate to Severe Asthma

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.